BioWorld Science

June 18, 2001

View Archived Issues

Shire to evaluate CX-516 in phase II for ADHD

Read More

Climodien continuous combined HRT cleared in E.U.

Read More

COX-2 inhibitor SVT-2016 characterized by good safety and suitable pharmacokinetics in man

Read More

Dainippon compound more potent than leflunomide in animal models of arthritis/autoimmune diseases

Read More

LDP-341 enters clinical trials in combination with gemcitabine and irinotecan

Read More

EULAR 2001: SMP-114 protects against both inflammation and joint destruction in arthritis

Read More

Genzyme substrate inhibitor compound shows advantages over first-generation inhibitors

Read More

FDA approves extended indication for delayed-release Protonix

Read More

Nymox discovers new family of compounds

Read More

Relpax approved in E.U. for migraine

Read More

Mucoregulators identified at Genaera with potential in COPD

Read More

Patient enrollment complete in safety trial with Miravant topical PhotoPoint drug

Read More

Selective presynaptic M2 antagonist facilitates acetylcholine release, improves cognition

Read More

Boehringer Ingelheim announces TRANSCEND trial in ACE-intolerant patients

Read More

Potent inhibitors of cGMP-PDE and potential uses reported in international patent

Read More

Takeda presents new compounds inhibiting steroid C17,20 lyase

Read More

Recent patent covers new NF-kB modulators from Aventis

Read More

Diaryl-enynes from NPS Allelix particularly useful for Alzheimer's disease

Read More

BMS synthesizes wide series of PTK inhibitors

Read More

Novel antibacterial agents designed by Abbott research team

Read More

Company Profile: GTx

Read More

BD Biosciences and Dyax to collaborate on antibody discovery

Read More

A novel ICP34.5-deleted HSV-1 virus for cancer therapy

Read More

Coagulin-B in second human hemophilia gene therapy trial

Read More